Urovant Sciences Reports 2019 Second Fiscal Quarter Financial Results
Tuesday, November 5th 2019 at 9:05pm UTC IRVINE, Calif. & BASEL, Switzerland–(BUSINESS WIRE)– Urovant Sciences (Nasdaq: UROV), a clinical-stage biopharmaceutical…
Tuesday, November 5th 2019 at 9:05pm UTC IRVINE, Calif. & BASEL, Switzerland–(BUSINESS WIRE)– Urovant Sciences (Nasdaq: UROV), a clinical-stage biopharmaceutical…
Tuesday, November 5th 2019 at 1:00pm UTC WATERTOWN, Mass.–(BUSINESS WIRE)– Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical company focused on commercializing…
Wednesday, November 6th 2019 at 12:00pm UTC Positive interim results announced from Phase 1 CMV vaccine (mRNA-1647) study Positive interim…
Wednesday, November 6th 2019 at 11:32am UTC ? Q3 2019 Net Revenue of $378 million; GAAP Loss per share of…
Tuesday, November 5th 2019 at 1:30pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines…
Tuesday, November 5th 2019 at 9:06pm UTC BEVERLY, Mass.–(BUSINESS WIRE)– American Renal Associates Holdings, Inc. (NYSE: ARA) (the “Company”), a…
Wednesday, November 6th 2019 at 1:15pm UTC SEATTLE–(BUSINESS WIRE)– Omeros Corporation (NASDAQ: OMER), today announced that the company will issue…
Tuesday, November 5th 2019 at 9:15pm UTC VANCOUVER, British Columbia–(BUSINESS WIRE)– Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing…
Tuesday, November 5th 2019 at 1:00pm UTC CARLSBAD, Calif.–(BUSINESS WIRE)– Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a…
Tuesday, November 5th 2019 at 1:00pm UTC BEDFORD, Mass.–(BUSINESS WIRE)– Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on…